Last reviewed · How we verify
NCT06067659
Comparison Of The Treatment Effects Of Different Methods In Patients With Calcaneal Spur
NA trial testing Extracorporeal shock wave therapy in Heel Spur in 30 participants. Completed in 9 December 2023.
20 November 2023
Quick facts
| Lead sponsor | University of Beykent |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 20 June 2023 |
| Primary completion | 20 November 2023 |
| Estimated completion | 9 December 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Extracorporeal shock wave therapy
- Kinesiology taping
- Extracorporeal shock wave therapy+Kinesiology taping
Conditions studied
- Heel Spur — all drugs for Heel Spur →
Sponsor
University of Beykent
Who can join
Adults 30 to 70, any sex, with Heel Spur. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Calcaneal spur (heel spur) is one of the most common disorders associated with foot pain. Patients may complain of pain at every step during the day, so it is important to find the most effective treatment method for patients. The aim of this study is to compare the therapeutic efficacy of extracorporeal shock wave therapy (ESWT) and kinesiology taping (KB) in patients with calcaneal spurs. Thirty patients with calcaneal spurs will be included in the study. The gender, age, body weight, height, body mass index, and affected side of the patients will be recorded. Patients will be randomly divided into three treatment groups: ESWT to the first group, KB therapy to the second group, and combined ESWT+KB to the third group. Each group will be treated for five sessions, once a week for five weeks. ESWT 15Hz frequency will be applied as 2.5 Barr energy and 2000 Shock/session. It will be applied with the KB I and fan method and the tape will not be removed for three days after the application. In the pre- and post-treatment evaluations of the patients, heel sensitivity and sensory perception will be evaluated with the Foot structure Foot Posture Index (API). Visual Analog Scale (VAS), Quality of Life Short Form-36 (SF-36), Foot Function Index (AFI) and Windlass Test will be used.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06067659
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Extracorporeal shock wave therapy
Trials testing the same drug.
- NCT07468734 — Shock Wave Versus Traditional Physical Therapy for Adult Chronic Knee Osteoarthritis · NA · recruiting
- NCT06469931 — Ozone Therapy in Patients With Carpal Tunnel Syndrome · NA · recruiting
- NCT06329154 — Clinical Study On Extracorporeal Shock Wave Therapy For Rotator Cuff Injuries · NA · unknown
- NCT06248905 — Shock Wave Therapy Plus Exercise in GTPS · NA · active not recruiting
- NCT06356064 — Radial or Focus Extracorporeal Shock Wave Therapy in Epin Calcanei · NA · completed
Other recruiting trials for Heel Spur
Currently open trials in the same condition.
- NCT06983457 — Comparative Effects of TherapeuticU and Shockwave Therapy on Pain and QOL in Patients With Chronic Heel Spur Pain · NA · active not recruiting
Other University of Beykent trials
Trials by the same sponsor.
- NCT07457398 — Effects of Gastrocnemius Fatigue on Muscle Elasticity and Jumping · NA · completed
- NCT07069283 — The Effect of Self-Compassion Practices on Nomophobia Symptoms in Young Adults · NA · not yet recruiting
- NCT06905548 — Climate Change Awareness: a Randomized Controlled Trial · NA · not yet recruiting
- NCT07160881 — Effectiveness of CPR Pillow · NA · enrolling by invitation
- NCT06828029 — Problem-Solving Approach Training on Professional Readiness Perception · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06067659 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Beykent
- Last refreshed: 18 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06067659.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing